Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)

ClinicalTrials.gov ID: NCT01114854

Public ClinicalTrials.gov record NCT01114854. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 8:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Conversion Study to Determine the Relative Bioavailability of TPM MR vs TPM IR in Subjects With Epilepsy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This multi-center, two-treatment study compares the pharmacokinetic profiles of Immediate Release (IR) and Modified Release (MR) formulations of Topiramate (TPM) in patients with epilepsy.

Study identification

NCT ID
NCT01114854
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Supernus Pharmaceuticals, Inc.
Industry
Enrollment
69 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2010 (Type not available)
Primary completion
Dec 2010 (Actual)
Completion
Jan 2011 (Actual)
Last update posted
May 18, 2017

2010 – 2011

United States locations

U.S. sites
9
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
Kyle Patrick Phoenix Arizona 85013 —
Victor Biton Little Rock Arkansas 72205 —
Mohammed Bari National City California 91950 —
Dr. Segal Fort Lauderdale Florida 33308 —
Dr. Sackellares Gainesville Florida 32607 —
James Kiely Atlanta Georgia 30342 —
Bassem El-Nabbout Wichita Kansas 67214 —
Dr. Chumley Lexington Kentucky 20513 —
Dr. Fisher Oklahoma City Oklahoma 73112 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01114854, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 18, 2017 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01114854 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →